How low oxygen helps the eye lens develop
Hypoxia regulation of the lens
This project looks at how very low oxygen in the developing eye helps lens cells turn on the genes they need to become clear and healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida Atlantic University NIH-funded |
| Lab location | 1 site (Boca Raton, United States) |
| Project ID | NIH-11251264 on NIH RePORTER |
What this research studies
If you care about lens health, this work explores why parts of the developing lens live in low-oxygen conditions and how that low oxygen tells lens cells to make the proteins they need to become transparent. Researchers focus on the hypoxia response molecule HIF1a and its partner proteins, using laboratory tissue work and genetically modified animal models to change oxygen levels or remove these regulators. They will examine changes in gene activity and epigenetic marks as lens cells mature and lose organelles. The team aims to connect those molecular changes to normal lens formation and to defects that can lead to clouding.
Who could benefit from this research
Good fit: Adults with lens problems (for example, cataracts) or people willing to donate eye tissue for research would be the most relevant participants or contributors.
Not a fit: People without lens or eye conditions or those seeking immediate clinical treatments are unlikely to get direct benefit from this basic science project.
Why it matters
Potential benefit: Understanding these oxygen-driven pathways could lead to new ways to prevent or treat lens clouding such as cataracts.
How similar studies have performed: Previous lab and animal studies have shown that oxygen levels and HIF1a influence lens development, but translating that to patient treatments remains unproven.
Where this research is happening
Boca Raton, United States
- Florida Atlantic University — Boca Raton, United States (Active)
Researchers
- Principal investigator: Kantorow, Marc — Florida Atlantic University
- Study coordinator: Kantorow, Marc
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.